Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Toxicologic Pathology
|
January 1, 1993
The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk
S J Gardell
The Journal of Biological Chemistry
|
September 5, 1992
Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis
P W Bergum, S J Gardell
The Journal of Biological Chemistry
|
May 25, 1983
Effects of bile acids and their glycine conjugates on gamma-glutamyl transpeptidase
S J Gardell, S S Tate
Thrombosis and Haemostasis
|
August 3, 1992
Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation
T R Hare, S J Gardell
The Journal of Biological Chemistry
|
June 25, 1979
Latent proteinase activity of gamma-glutamyl transpeptidase light subunit
S J Gardell, S S Tate
Circulation
|
March 1, 1995
Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model
M Montoney, S J Gardell, V J Marder
The Journal of Biological Chemistry
|
May 5, 1991
Combinatorial mutagenesis of the reactive site region in plasminogen activator inhibitor I
J D York, P Li, S J Gardell
Thrombosis Research
|
February 1, 1995
Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor
X P Shi, K C Yin, S J Gardell
The Journal of Biological Chemistry
|
January 15, 1987
Use of directed mutagenesis to probe the role of tyrosine 198 in the catalytic mechanism of carboxypeptidase A
S J Gardell, D Hilvert, J Barnett, et al.
Blood
|
October 15, 1990
The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit
E J Mayer, T Fujita, S J Gardell, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Toxicologic Pathology
|
January 1, 1993
The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk
S J Gardell
The Journal of Biological Chemistry
|
September 5, 1992
Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis
P W Bergum, S J Gardell
The Journal of Biological Chemistry
|
May 25, 1983
Effects of bile acids and their glycine conjugates on gamma-glutamyl transpeptidase
S J Gardell, S S Tate
Thrombosis and Haemostasis
|
August 3, 1992
Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation
T R Hare, S J Gardell
The Journal of Biological Chemistry
|
June 25, 1979
Latent proteinase activity of gamma-glutamyl transpeptidase light subunit
S J Gardell, S S Tate
Circulation
|
March 1, 1995
Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model
M Montoney, S J Gardell, V J Marder
The Journal of Biological Chemistry
|
May 5, 1991
Combinatorial mutagenesis of the reactive site region in plasminogen activator inhibitor I
J D York, P Li, S J Gardell
Thrombosis Research
|
February 1, 1995
Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor
X P Shi, K C Yin, S J Gardell
The Journal of Biological Chemistry
|
January 15, 1987
Use of directed mutagenesis to probe the role of tyrosine 198 in the catalytic mechanism of carboxypeptidase A
S J Gardell, D Hilvert, J Barnett, et al.
Blood
|
October 15, 1990
The pharmacokinetics of plasminogen activator inhibitor-1 in the rabbit
E J Mayer, T Fujita, S J Gardell, et al.
Page
of 4